✦ LIBER ✦

Long-term strategies for the treatment of Refsum's disease using therapeutic apheresis

✍ Scribed by D. Zolotov; S. Wagner; K. Kalb; J. Bunia; A. Heibges; R. Klingel

Book ID: 112119642
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 891 KB
Volume: 27
Category: Article
ISSN: 0733-2459
DOI: 10.1002/jca.21200

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phytanic acid storage disease (Refsum's

Phytanic acid storage disease (Refsum's disease): Clinical characteristics, pathophysiology and the role of therapeutic apheresis in its management

✍ Robert Weinstein 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 26 KB 👁 2 views

Phytanic acid storage disease (known also as Refsum's Disease) is caused by inherited defects in the metabolic pathway for phytanic acid, a dietary branched-chain fatty acid. Poorly metabolized phytanic acid accumulates in fatty tissues, including myelin sheaths, and in organs including the liver an

Emerging therapeutic strategies for the

Emerging therapeutic strategies for the treatment of fabry disease

✍ Tim Edmunds 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 297 KB

Lazabemide for the long-term treatment o

Lazabemide for the long-term treatment of Alzheimer's disease

✍ G. Magni; R.C. Meibach 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Long-term effectiveness of behavioral tr

Long-term effectiveness of behavioral treatments for Raynaud's disease

✍ Robert R. Freedman 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 878 KB

Strategies for the development of therap

Strategies for the development of therapeutics for Alzheimer's disease

✍ Peter Davies 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 248 KB

Long-term cost-effectiveness of donepezi

Long-term cost-effectiveness of donepezil for the treatment of Alzheimer’s disease

✍ Stefan J. Teipel; Michael Ewers; Veronika Reisig; Bernd Schweikert; Harald Hampe 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 252 KB